TrialBMC cancer2013

S-1 combined with docetaxel following doxorubicin plus cyclophosphamide as neoadjuvant therapy in breast cancer: phase II trial.

Yong Wha Moon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.